Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.80%18.01B | 7.02%15.83B | 7.14%4.02B | 3.89%3.98B | 5.31%3.85B | 12.04%3.97B | 12.90%14.79B | 7.75%3.75B | 17.43%3.83B | 12.82%3.65B |
| Cost of revenue | 16.58%9.99B | 1.84%8.57B | 3.49%2.25B | 0.38%2.1B | -1.22%2.1B | 4.82%2.11B | 10.85%8.41B | 2.35%2.18B | 12.27%2.1B | 14.73%2.13B |
| Gross profit | 10.52%8.02B | 13.85%7.26B | 12.20%1.77B | 8.05%1.88B | 14.55%1.75B | 21.42%1.87B | 15.74%6.38B | 16.16%1.57B | 24.46%1.74B | 10.10%1.53B |
| Operating expense | 24.77%4.68B | 24.63%3.75B | 30.97%1.13B | 40.72%1.02B | 21.15%802M | 5.46%811M | 17.47%3.01B | 19.14%859M | 16.83%722M | 6.26%662M |
| Operating profit | -4.74%3.34B | 4.19%3.51B | -10.35%641M | -15.13%864M | 9.49%946M | 37.42%1.05B | 14.23%3.36B | 12.78%715M | 30.51%1.02B | 13.24%864M |
| Net non-operating interest income (expenses) | -58.33%-38M | 27.27%-24M | 14.29%-6M | 37.50%-5M | 22.22%-7M | 33.33%-6M | 19.51%-33M | 36.36%-7M | 11.11%-8M | 18.18%-9M |
| Non-operating interest expense | 58.33%38M | -27.27%24M | -14.29%6M | -37.50%5M | -22.22%7M | -33.33%6M | -19.51%33M | -36.36%7M | -11.11%8M | -18.18%9M |
| Net investment income | -471.43%-26M | 130.43%7M | 0 | 87.50%-2M | -155.56%-23M | 142.86%3M | 150.00%2M | -1,300.00%-12M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 10.94%-293M | 23.13%-329M | 19.30%-301M | 105.88%1M | 70.59%-15M | -207.69%-14M | -95.43%-428M | -54.77%-373M | -750.00%-17M | -1,600.00%-51M |
| Less:Restructuring and mergern&acquisition | ---16M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 458.82%61M | -54.55%-17M | 383.33%29M | -120.00%-1M | -555.56%-59M | 207.69%14M | 38.89%-11M | 50.00%6M | 150.00%5M | -400.00%-9M |
| Less:Write off | -28.32%248M | -21.18%346M | -25.89%272M | --0 | ---- | ---- | 85.23%439M | 54.85%367M | --12M | ---- |
| Other non-operating income (expenses) | -30.36%39M | -28.21%56M | 27.27%14M | -56.00%11M | -9.09%20M | -45.00%11M | 387.50%78M | 175.00%11M | 600.00%25M | 69.23%22M |
| Income before tax | -5.92%3.02B | 8.66%3.21B | 1.44%352M | -14.41%873M | 16.09%945M | 34.50%1.04B | 9.85%2.96B | -8.20%347M | 34.21%1.02B | 6.96%814M |
| Income tax | -8.56%994M | 4.42%1.09B | -10.53%119M | -9.57%312M | 10.75%340M | 23.44%316M | 5.36%1.04B | -22.22%133M | 19.79%345M | 10.83%307M |
| Net income | -4.57%2.03B | 10.92%2.12B | 8.41%232M | -17.01%561M | 19.33%605M | 40.23%725M | 12.46%1.91B | 2.88%214M | 43.52%676M | 4.54%507M |
| Net income continuous operations | -4.57%2.03B | 10.97%2.12B | 8.88%233M | -16.89%561M | 19.33%605M | 39.96%725M | 12.46%1.91B | 3.38%214M | 43.01%675M | 4.75%507M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -4.57%2.03B | 10.92%2.12B | 8.41%232M | -17.01%561M | 19.33%605M | 40.23%725M | 12.46%1.91B | 2.88%214M | 43.52%676M | 4.54%507M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -4.57%2.03B | 10.92%2.12B | 8.41%232M | -17.01%561M | 19.33%605M | 40.23%725M | 12.46%1.91B | 2.88%214M | 43.52%676M | 4.54%507M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -4.64%108.19 | 10.82%113.45 | 8.39%12.4 | -17.13%29.94 | 19.38%32.34 | 39.91%38.77 | 12.43%102.37 | 3.25%11.44 | 43.32%36.13 | 4.31%27.09 |
| Diluted earnings per share | -4.64%106.78 | 10.84%111.97 | 8.41%12.24 | -17.11%29.55 | 19.37%31.92 | 39.94%38.26 | 12.46%101.02 | 3.29%11.29 | 43.35%35.65 | 4.33%26.74 |
| Dividend per share | 0.00%45 | 80.00%45 | 133.33%35 | 0 | 0.00%10 | 0 | 108.33%25 | 50.00%15 | 0 | 400.00%10 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |